12,194 Followers on Owler

Bio-Rad

Bio-Rad Laboratories manufactures, develops, and markets laboratory and medical testing instruments for life sciences and clinical diagnostics. Read more

Norman Schwartz's photo - Chairman & CEO of Bio-Rad

Chairman & CEO

Norman Schwartz

CEO Approval Rating

79/100

Founded:

1952

Status:

PublicIndependent CompanyNYSEBIO

BIO-RAD TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

BD is seen as one of Bio-Rad's top competitors. BD was founded in Franklin Lakes, New Jersey} in 1897. BD is in the Health Care Equipment industry. Compared to Bio-Rad, BD generates $16.2B more revenue.

Merck Millipore is Bio-Rad's #2 competitor. Merck Millipore was founded in 1954, and its headquarters is in Darmstadt, Hesse. Merck Millipore is in the Scientific Research field. Merck Millipore has 11,750 more employees than Bio-Rad.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Abbott a competitor of Bio-Rad?

Bio-Rad Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.7B

Bio-Rad's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 12.7B. Over the last four quarters, Bio-Rad's revenue has grown by 35.4%. Specifically, in Q1 2021's revenue was $726.8M; in Q4 2020, it was $789.8M; in Q3 2020, it was $647.3M; in Q2 2020, Bio-Rad's revenue was $536.9M.

Bio-Rad Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Celsee, Inc.

Apr 2020

Source »
undisclosed
Celsee offers single-cell cytometry, proteogenomics, transcriptomics and immune monitoring solutions for the healthcare sector.
Exact Diagnostics LLC.

Aug 2019

Source »
undisclosed
-
RainDance Technologies, Inc.

Jan 2017

Source »
undisclosed
RainDance is a provider of genetic analysis solutions for the early detection of cancer and infectious diseases.
GnuBIO, Inc.

Apr 2014

Source »
undisclosed
GnuBio is a life sciences company that develops a droplet-based DNA sequencing technology solutions.

-

AbD Serotec Inc

Dec 2012

Source »
$70M
-

These are all the companies that Bio-Rad has acquired. Bio-Rad has acquired 16 companies and its latest acquisition was Celsee, Inc. in Apr 2020. Celsee offers single-cell cytometry, proteogenomics, transcriptomics and immune monitoring solutions for the healthcare sector.

Bio-Rad Funding History

No recent funding data found related to Bio-Rad

Bio-Rad Investments

No recent investments found related to Bio-Rad

These are all the companies that Bio-Rad has invested in. Bio-Rad has invested 16 companies and its latest investment was Celsee, Inc. in Apr 2020. Celsee offers single-cell cytometry, proteogenomics, transcriptomics and immune monitoring solutions for the healthcare sector.

Bio-Rad News

May 20, 2021MarketScreener

Rad to Participate at Jefferies Virtual Healthcare Conference

(marketscreener.com) Bio-Rad Laboratories, Inc. , a global leader of life science research and clinic... See more »
May 20, 2021Clinical Lab Products

Bio-Rad Launches InteliQ Diabetes Load-and-Go Quality Control

The InteliQ Diabetes Control includes three distinct levels that may address the HbA1c precision moni... See more »
May 6, 2021Lab Bulletin

Bio-Rad Launches Its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products... See more »
April 29, 2021Genomeweb

Bio-Rad Q1 Revenues Rise 27 Percent, Beat Estimates

The firm's quarterly revenues and EPS were well ahead of analysts' expectations, with growth attribut... See more »
April 27, 2021Lab Bulletin

Bio-Rad Launches SARS-CoV-2 Variant RT-PCR Assays

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products... See more »
April 22, 2021LabOnline

Bio-Rad Laboratories SARS-CoV-2 Variant RT-PCR Assays

Bio-Rad Laboratories has launched its SARS-CoV-2 Variant RT-PCR Assays for research use only (RUO). T... See more »
April 15, 2021BioSpace

Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinica... See more »

Bio-Rad Press Releases

July 15, 2019Newswise

Bio-Rad Announces Innovative Test to Aid in the Diagnosis of Lyme Disease with the FDA Clearance of the BioPlex 2200 Lyme Total Assay

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinica... See more »
April 23, 2019Business Wire

Bio-Rad to Participate in the Bank of America Merrill Lynch Health Care Conference 2019 in May

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader o... See more »
December 4, 2018PRWeb

Luminex and Bio-Rad Sponsor Webinar to Provide Overview of Bead-Based Multiplexing Technology for Research Use with Mouse Samples

In this webinar on December 5, attendees will learn what xMAP® Technology is, how it is used, and the... See more »
May 8, 2018StreetInsider

Bio-Rad Reports First Quarter 2018 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinica... See more »
March 6, 2018Business Wire

Bio-Rad to Present at Barclays Global Healthcare Conference 2018 on March 14

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader o... See more »

Bio-Rad Videos

Social Media

Bio-Rad Headquarters

2000 Alfred Nobel Drive

Hercules, California94547

1-510-741-1000

Driving Directions »

Trending Companies

Bio-Rad Summary

ABOUT

Overview

Bio-Rad Laboratories, Inc. (NYSE: BIO) manufactures, develops, and markets laboratory and medical testing instruments for life sciences and clinical diagnostics. Founded in 1952, Bio-Rad serves life science research and clinical diagnostics customers ...

CEO

Bio-Rad's Chairman & CEO, Norman Schwartz, currently has an approval rating of 79%. Bio-Rad's primary competitors are BD, GE Healthcare Life Sciences & Merck Millipore.

Frequently Asked Questions about Bio-Rad

  1. When was Bio-Rad founded?

    Bio-Rad was founded in 1952
  2. Who is Bio-Rad's CEO?

    Bio-Rad's CEO is Norman Schwartz
  3. How much revenue does Bio-Rad generate?

    Bio-Rad generates $2.7B in revenue
  4. How much funding does Bio-Rad have?

    Bio-Rad has historically raised $0 in funding
  1. Where is Bio-Rad's headquarters?

    Bio-Rad's headquarters is in Hercules California, USA
  2. How many employees does Bio-Rad have?

    Bio-Rad has 8,250 employees
  3. What sector does Bio-Rad operate in?

    Bio-Rad is in Health Care Supplies, Health Care Equipment
  4. Who are Bio-Rad's competitors?

    Bio-Rad's top competitors are BD, GE Healthcare Life Sciences, Merck Millipore